Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. | Ther Adv Musculoskelet Dis | 2020 | 33403019 | PubTator, text mining | PubMed |
| Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease. | Front Pharmacol | 2020 | 33384602 | PubTator, text mining | PubMed |
| Genome-Wide Analysis of LysM-Containing Gene Family in Wheat: Structural and Phylogenetic Analysis during Development and Defense. | Genes (Basel) | 2020 | 33383636 | PubTator, text mining | PubMed |
| Associating Emergency Medical Services personnel's workload, trauma exposure, and health with the cortisol, endocannabinoid, and N-acylethanolamine concentrations in their hair. | Sci Rep | 2020 | 33376241 | PubTator, text mining | PubMed |
| Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement. | Front Immunol | 2020 | 33362801 | PubTator, text mining | PubMed |
| Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD? | Front Immunol | 2020 | 33362797 | PubTator, text mining | PubMed |
| COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes. | Front Pediatr | 2020 | 33330288 | PubTator, text mining | PubMed |
| HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. | Front Immunol | 2020 | 33329575 | PubTator, text mining | PubMed |
| Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT. | Front Immunol | 2020 | 33324410 | PubTator, text mining | PubMed |
| Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance. | Cancers (Basel) | 2020 | 33316942 | PubTator, text mining | PubMed |
| Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse. | Biomark Res | 2020 | 33298182 | PubTator, text mining | PubMed |
| Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK. | Int J Mol Sci | 2020 | 33291717 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibition Promotes Myelin Repair. | Brain Plast | 2020 | 33282676 | PubTator, text mining | PubMed |
| Managing toxicities of Bruton tyrosine kinase inhibitors. | Hematology Am Soc Hematol Educ Program | 2020 | 33275698 | PubTator, text mining | PubMed |
| Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers. | Asian Pac J Cancer Prev | 2020 | 33247676 | PubTator, text mining | PubMed |
| Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse. | Front Immunol | 2020 | 33240268 | PubTator, text mining | PubMed |
| Updates on new monogenic inborn errors of immunity. | Pediatr Allergy Immunol | 2020 | 33236415 | PubTator, text mining | PubMed |
| An integrative atlas of chicken long non-coding genes and their annotations across 25 tissues. | Sci Rep | 2020 | 33235280 | PubTator, text mining | PubMed |
| Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia. | Int J Mol Sci | 2020 | 33233470 | PubTator, text mining | PubMed |
| Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report. | BMC Infect Dis | 2020 | 33228556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=57